Daniella Beckman

At Tango, Beckman oversees finance, investor relations, and business development. Previously, she was a consultant to early-stage biothechnology companies. She also served as interim CFO for Neon Therapeutics and CFO of Idenix Pharmaceuticals. She currently serves on the board of Translate Bio.

  • October 2020

Added to: Vor Biopharma - Cambridge, MA

Vor Biopharma is an oncology company pioneering engineered hematopoietic stem cell therapies  for the treatment of cancer. Vor's platform could be used to improve the treatment paradigm for patients with blood cancers such as acute myeloid leukemia.